Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)
300584.SZ Stock Price Chart
Explore Nanjing Hicin Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300584.SZ price movements and trends.
300584.SZ Company Profile
Discover essential business fundamentals and corporate details for Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
12 Jan 2017
Employees
553.00
Website
https://www.hicin.cnCEO
Yuping Cao
Description
Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
300584.SZ Financial Timeline
Browse a chronological timeline of Nanjing Hicin Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 9 Jun 2025
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 9 Jun 2025.
Earnings released on 15 May 2025
EPS came in at ¥0.10 , while revenue for the quarter reached ¥143.86M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.13 , while revenue for the quarter reached ¥142.65M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥123.97M .
Earnings released on 29 Jun 2024
EPS came in at ¥0.09 , while revenue for the quarter reached ¥129.02M .
Dividend declared on 18 Jun 2024
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 18 Jun 2024.
Earnings released on 15 May 2024
EPS came in at ¥0.12 , while revenue for the quarter reached ¥136.98M .
Earnings released on 30 Mar 2024
EPS came in at ¥0.11 , while revenue for the quarter reached ¥102.15M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥116.40M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥144.35M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.10 , while revenue for the quarter reached ¥117.20M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.10 , while revenue for the quarter reached ¥147.25M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥111.63M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥116.97M .
Dividend declared on 25 May 2022
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 25 May 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.11 , while revenue for the quarter reached ¥150.61M .
Earnings released on 31 Dec 2021
EPS came in at ¥2.15 , while revenue for the quarter reached ¥124.79M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.06 , while revenue for the quarter reached ¥136.62M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.06 , while revenue for the quarter reached ¥154.70M .
Dividend declared on 13 May 2021
A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 13 May 2021.
Earnings released on 23 Apr 2021
EPS came in at ¥0.06 , while revenue for the quarter reached ¥158.34M .
Earnings released on 8 Apr 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥162.20M .
Earnings released on 29 Oct 2020
EPS came in at ¥0.10 , while revenue for the quarter reached ¥172.11M .
300584.SZ Stock Performance
Access detailed 300584.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.